Bank of New York Mellon’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-476,499
| Closed | -$38M | – | 4529 |
|
|
2021
Q1 | $38M | Sell |
476,499
-25,113
| -5% | -$1.96M | 0.01% | 1296 |
|
|
2020
Q4 | $39.6M | Sell |
501,612
-26,539
| -5% | -$1.56M | 0.01% | 1196 |
|
|
2020
Q3 | $23.2M | Buy |
528,151
+101,744
| +24% | +$5.01M | 0.01% | 1379 |
|
|
2020
Q2 | $18.9M | Buy |
426,407
+19,673
| +5% | +$734K | 0.01% | 1479 |
|
|
2020
Q1 | $14.6M | Sell |
406,734
-13,782
| -3% | -$784K | ﹤0.01% | 1487 |
|
|
2019
Q4 | $29.8M | Sell |
420,516
-2,034
| -0.5% | -$148K | 0.01% | 1320 |
|
|
2019
Q3 | $31.6M | Sell |
422,550
-3,667
| -0.9% | -$311K | 0.01% | 1235 |
|
|
2019
Q2 | $34.4M | Sell |
426,217
-6,908
| -2% | -$486K | 0.01% | 1211 |
|
|
2019
Q1 | $29M | Sell |
433,125
-58,859
| -12% | -$4.46M | 0.01% | 1313 |
|
|
2018
Q4 | $36.6M | Sell |
491,984
-27,945
| -5% | -$2.31M | 0.01% | 1089 |
|
|
2018
Q3 | $47.9M | Buy |
519,929
+82,946
| +19% | +$7.9M | 0.01% | 1050 |
|
|
2018
Q2 | $43M | Sell |
436,983
-4,697
| -1% | -$525K | 0.01% | 1105 |
|
|
2018
Q1 | $49.2M | Sell |
441,680
-23,922
| -5% | -$2.68M | 0.01% | 1014 |
|
|
2017
Q4 | $47.9M | Sell |
465,602
-11,264
| -2% | -$1.12M | 0.01% | 1047 |
|
|
2017
Q3 | $44.9M | Sell |
476,866
-20,102
| -4% | -$1.59M | 0.01% | 1058 |
|
|
2017
Q2 | $38.7M | Sell |
496,968
-14,507
| -3% | -$1.09M | 0.01% | 1125 |
|
|
2017
Q1 | $41M | Sell |
511,475
-155,549
| -23% | -$12.4M | 0.01% | 1075 |
|
|
2016
Q4 | $52.5M | Buy |
667,024
+3,550
| +0.5% | +$276K | 0.02% | 913 |
|
|
2016
Q3 | $51.7M | Buy |
663,474
+13,202
| +2% | +$958K | 0.02% | 860 |
|
|
2016
Q2 | $44.7M | Sell |
650,272
-20,463
| -3% | -$1.41M | 0.01% | 928 |
|
|
2016
Q1 | $47.9M | Buy |
670,735
+214,142
| +47% | +$13.4M | 0.01% | 885 |
|
|
2015
Q4 | $28.4M | Sell |
456,593
-1,576
| -0.3% | -$96.1K | 0.01% | 1168 |
|
|
2015
Q3 | $26M | Buy |
458,169
+68,623
| +18% | +$3.63M | 0.01% | 1238 |
|
|
2015
Q2 | $20.9M | Buy |
389,546
+8,008
| +2% | +$390K | 0.01% | 1459 |
|
|
2015
Q1 | $18.1M | Sell |
381,538
-158,371
| -29% | -$7.01M | ﹤0.01% | 1580 |
|
|
2014
Q4 | $23.4M | Sell |
539,909
-29,401
| -5% | -$1.2M | 0.01% | 1354 |
|
|
2014
Q3 | $19.6M | Sell |
569,310
-7,162
| -1% | -$253K | 0.01% | 1442 |
|
|
2014
Q2 | $21.1M | Sell |
576,472
-11,450
| -2% | -$388K | 0.01% | 1442 |
|
|
2014
Q1 | $19.8M | Buy |
587,922
+185,280
| +46% | +$6.11M | 0.01% | 1458 |
|
|
2013
Q4 | $13.7M | Sell |
402,642
-25,655
| -6% | -$889K | ﹤0.01% | 1696 |
|
|
2013
Q3 | $13.6M | Sell |
428,297
-54,474
| -11% | -$1.45M | ﹤0.01% | 1653 |
|
|
2013
Q2 | $10.9M | Buy |
+482,771
| New | +$10.5M | ﹤0.01% | 1739 |
|
Bank of New York Mellon's CMD Position: Q2 2021 in Review
Bank of New York Mellon sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 476,499 shares — an estimated $38M sold.
Bank of New York Mellon first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $52.5M in Q4 2016. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Bank of New York Mellon reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Bank of New York Mellon sold 476,499 Cantel Medical Corporation shares in Q2 2021, an estimated $38M.
- Bank of New York Mellon first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Bank of New York Mellon's Cantel Medical Corporation position peaked at $52.5M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.